covid 19 News and Research

RSS

Why a major hydroxychloroquine study was retracted over statistical misuse

Researchers reanalyzed a retracted HCQ study that claimed over 16,000 COVID-19 deaths and exposed serious methodological flaws, including inappropriate use of effect sizes and lack of dose-specific analysis. The study calls for urgent reform in peer review and greater transparency in scientific publishing.

6 May 2025

How microRNA is transforming science: From discovery to diagnostics

In this interview, industry expert Dr. Lohit Khera discusses the evolving role of microRNA in research, diagnostics, and precision medicine, highlighting the latest innovations in RNA extraction and analysis

From Norgen Biotek Corp. 6 May 2025

Breakthrough brain training shows promise for Long COVID recovery

Researchers at the University of Alabama at Birmingham (UAB) have identified what is believed to be the first intervention found in a randomized controlled trial to show large and very large improvements in multiple symptoms associated with Long COVID, and to result in people debilitated by those symptoms returning to work.

5 May 2025

Scientists use AI to build mutation-proof antibodies for SARS-CoV-2

Researchers used AI models to design antibodies that neutralize over 1,300 SARS-CoV-2 strains, including Delta and Omicron. The models demonstrated faster, cheaper, and more adaptable therapeutic development compared to traditional methods.

5 May 2025

UVA findings hold promise for developing targeted treatments for Long COVID lung complications

Groundbreaking research from the University of Virginia School of Medicine has revealed crucial new insights into the immune systems of COVID-19 survivors, particularly those struggling with persistent breathing issues.

5 May 2025

CEPI and University of Bergen collaborate on global vaccine mapping project

Supported by CEPI funding of up to $ 1.5 million over three years, researchers at Norway's University of Bergen will maintain an up-to-date overview of every vaccine candidate being developed around the globe for CEPI's priority pathogens as well as other emerging viral threats identified by CEPI.

5 May 2025

Trump team’s $500 million bet on old vaccine technology puzzles scientists

The Trump administration's unprecedented $500 million grant for a broadly protective flu shot has confounded vaccine and pandemic preparedness experts, who said the project was in early stages, relied on old technology, and was just one of more than 200 such efforts.

5 May 2025

Celebrating two years in Malaysia: New Vision Display’s manufacturing expansion supports greater customer growth and resilience

New Vision Display (NVD), a Shenzhen-based company, is celebrating two years of successful manufacturing operations at its Malaysia facility — a major milestone in the company’s strategy to better support customer growth, mitigate risk, and strengthen supply chain resilience across the Southeast Asia region and beyond.

From New Vision Display 2 May 2025

COVID-19 leaves longer-lasting symptoms than flu or pneumonia, study finds

A large U.S. cohort study found that post-acute symptoms after COVID-19 vary by initial disease severity, age, sex, and comorbidities. Compared to influenza and pneumonia, long COVID presented with distinct symptom patterns and longer-lasting effects.

1 May 2025

Clinical trial underway to assess effectiveness and safety of potential Long Covid treatment

A clinical trial is underway to assess the effectiveness and safety of sipavibart, AstraZeneca's long-acting monoclonal antibody designed to provide protection against Covid-19, as a potential treatment for Long Covid, the Nova Southeastern University (NSU) and the Schmidt Initiative for Long Covid (SILC) announced today.

1 May 2025

COVID-19 restrictions linked to better birth timing but worse mental health

A global review reveals that while lockdowns helped reduce early births in some regions, they also worsened maternal mental health, highlighting the need for more tailored support during future health crises.

1 May 2025

HHS and NIH announce the development of next-generation, universal vaccine platform

Colorized transmission electron micrograph of influenza A/H1N1 virus particles. The U.S. Department of Health and Human Services (HHS) and the National Institutes for Health (NIH) today announced the development of the next-generation, universal vaccine platform, Generation Gold Standard, using a beta-propiolactone (BPL)-inactivated, whole-virus platform.

1 May 2025

Researchers identify blood biomarkers linked to Long COVID symptoms

Researchers at Karolinska Institutet have identified biomarkers in the blood associated with symptoms of long COVID, particularly severe respiratory disorders.

30 Apr 2025

Urgent action needed to close gaps in global pandemic preparedness

The Global Virus Network (GVN) is highly concerned that the world is unprepared for the next pandemic and has not incorporated the lessons learned from COVID-19.

30 Apr 2025

New antiviral compounds show broad protection against COVID-19 variants

Novel Mpro inhibitors exhibit broad activity against SARS-CoV-2 and other coronaviruses.

30 Apr 2025

Why different loneliness tests still identify the same emotional struggles

Researchers examined how loneliness classifications, by frequency, distress, or chronicity, relate to cognitive and behavioral traits in 790 adults. Despite modest agreement between classification methods, the study found consistent psychological patterns among lonely individuals across all types of loneliness.

29 Apr 2025

Measles makes a deadly comeback in Europe as vaccine gaps widen

In 2024, measles cases in Europe soared to the highest levels in decades, with over 35,000 reported cases, 87% from Romania alone. Most affected were unvaccinated children, revealing critical immunity gaps and suboptimal vaccination coverage across the EU/EEA.

29 Apr 2025

Celebrating 25 years of GOARN's global health impact

The Global Outbreak Alert and Response Network (GOARN), an initiative coordinated by the World Health Organization (WHO), marks its 25th anniversary today.

29 Apr 2025

How immune resilience and salutogenesis promote disease resistance and longevity

Researchers examine how salutogenesis, the active production of health through immune resilience, resists disease.

28 Apr 2025

Ultra-processed foods make up nearly half of US grocery purchases, raising public health concerns

A 2025 study of nearly 60,000 US households found that almost half of grocery purchases were ultra-processed foods (UPFs), with major disparities based on income, education, and race. Non-Hispanic white households led in UPF purchases, especially in beverages, reversing earlier trends.

28 Apr 2025